Real due diligence requires talking to the company and those in the industry and I have done both
Insmed does not have another drug called iplex that is in their 5 year plan.(They have some worthless rights).
Insmeds Cystic Fibrosis market will be in a cluster of competition .Novartis is and will be the leader
The "unmet need" is for less than 20% of those 100 thousand patients.
I have an opinion that Insmed will get bought out for under $50 in the next 3 years.
I bought more on this dip. I am the only one that answered without some mindless nonsense.
Welcome Kimm, soon you will be called "Terry! . As you can see by the responses they are juveniles.(so far as investors). They are actually adults who exhibit a sentiment of this company for the ill informed, a beautiful short play............ve got mail! ...